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3Abstract
Background:	People	living	with	rare	neurological	conditions	(RNCs)	often	face	common	physical,
cognitive	and	psychological	challenges	that	lead	to	reduced	physical	activity	and	associated
deconditioning.	Physical	activity	interventions	are	routinely	utilised	to	address	disease	specific
limitations	with	the	intention	of	promoting	participation	in	people	with	RNCs.	This	scoping	review
aimed	to	synthesise	the	body	of	evidence	for	such	interventions	as	they	are	applied	across	a	wide
range	of	RNCs.	
Methods:	We	undertook	a	scoping	review	of	systematic	reviews	of	any	type	of	physical	activity	and
exercise	interventions	for	adults	with	neuromuscular	diseases,	motor	neurone	disease,	Huntington’s
disease,	progressive	supranuclear	palsy,	multiple	system	atrophy,	inherited	ataxias	and	hereditary
spastic	paraplegia.	The	reviews	were	included	if	they	reported	at	least	one	outcome	that	aimed	to
increase	physical	activity	level	at	either	the	body	structure/function,	activity	and/or	participation
levels.
Results:	Sixty-two	articles	were	full-text	screened	of	which	27	were	included.	Most	studies	involved
interventions	in	people	with	neuromuscular	diseases.	No	reviews	of	interventions	in	hereditary	spastic
paraparesis	were	identified.	The	majority	of	reviews	included	studies	of	structured	exercise	using
outcome	measures	at	the	level	of	body	function	and	functional	activity.	Interventions	were	grouped
as:	i)	combined	interventions;	ii)	muscle	strength	training;	iii)	respiratory	training;	iv)	aerobic
training.	Frequency,	intensity,	time	and	type	of	structured	exercise	utilised	varied	considerably	across
studies.	Most	studies	were	methodologically	limited	by	small	sample	sizes,	variation	in	exercise	dose
and	training	duration.
Conclusions:	To	date,	primary	attention	has	been	given	to	structured	exercise	interventions,	which
have	demonstrated	to	have	a	low	to	uncertain	level	of	evidence.	Novel	approaches	to	implementing
common	interventions	and	modalities	are	needed	to	increase	accessibility	and	engagement	in
physical	activity	irrespective	of	disease	type.	Further	exploration	is	warranted	to	achieve	consensus
on	outcome	measures	that	reflect	areas	of	importance	and	relevance	to	people	with	RNCs.
Introduction
4Rare	neurological	conditions	(RNCs)	describe	a	heterogeneous	group	encompassing	disorders	such	as
neuromuscular	diseases	(NMDs),	motor	neurone	disease	(MND),	Huntington’s	disease	(HD),
progressive	supranuclear	palsy	(PSP),	multiple	system	atrophy	(MSA),	inherited	ataxias	and	hereditary
spastic	paraplegia	(HSP).	As	a	collective	group,	all	rare	conditions	have	a	global	prevalence	of	40
cases	per	100,000	population	(1),	and	it	is	estimated	that	5-8%	of	the	European	population	are
affected	by	a	rare	disease	(2).
Due	to	their	progressive	long-term	nature,	RNCs	taken	together	cause	a	significant	cost	burden	on
health	and	social	care	services	(for	example	due	to	delays	in	obtaining	a	diagnosis	and	consequent
long-term	care)	and,	and	incur	hidden	costs	related	to	informal	care	and	family	support	(3).	For	this
reason,	experts	in	this	field	recommend	a	united	approach	that	takes	into	account	the	entire
spectrum	of	RNCs,	to	enable	appropriate	understanding	and	management	of	patients	with	these
diseases	(2).
People	with	neurological	disabilities	are	as	twice	as	likely	to	be	inactive	compared	to	non-disabled
people	(4).	This	sedentary	lifestyle	increases	the	risk	for	the	development	of	non-communicable
diseases,	with	an	associated	20-30%	increased	risk	of	all-cause	mortality	(5).	Most	importantly,
people	living	with	RNCs	face	common	challenges	in	daily	life,	not	only	physical	(e.g.	fatigue,	poor
balance,	pain),	but	also	cognitive	and	psychological	(e.g.	low	mood	or	motivation),	resulting	in	a	great
reduction	in	participation	in	daily	activities	and	a	sedentary	lifestyle	(6-11).
Physical	activity	and	exercise	interventions	tailored	to	people	living	with	RNCs	are	generally	promoted
in	national	and	international	guidelines	(12-14).	These	interventions	widely	comprise	“Any	bodily
movement	produced	by	skeletal	muscles	that	requires	energy	expenditure”	and	any	type	of
structured	exercise	(15)	including	gait	and	balance	training,	video-gaming	(16-18)	and	cognitive
behaviour	interventions	(19-21).	However,	although	physical	activities	are	promoted	as	an	essential
part	of	the	clinical	management	across	RNCs,	evidence	supporting	physical	activity	interventions	is
still	lacking	in	these	conditions	(22-27).	To	date,	there	are	significant	gaps	in	understanding	about
which	types	of	activities	maintain	physical	functioning	and	increase	participation	in	activities	and
quality	of	life	across	RNCs.
5Previously,	systematic	reviews	have	investigated	the	level	of	evidence	for	physical	interventions	in
specific	RNCs.	For	example,	reviews	have	investigated	the	safety	and	efficacy	of	strength	and	aerobic
training	in	people	with	NMDs	(27,	28),	while	another	review	assessed	the	effect	of	respiratory	function
in	patients	with	MND	(29).
As	no	reviews	have	collectively	synthesised	the	existing	evidence	in	support	of	physical	activity	and
exercise	interventions	across	the	wide	spectrum	of	RNCs,	the	overarching	aim	of	this	scoping	review
was	to	synthesise	the	body	of	evidence	in	relation	to	those	interventions	that	seek	a	change	in
physical	conditioning,	functioning	and	participation	in	those	living	with	RNCs.
	
Methods
Protocol
This	scoping	review	of	systematic	reviews,	was	conducted	according	to	the	methodology	outlined	in
the	Joanna	Briggs	Institute	(JBI)	Reviewers’	Manual	(30)	and	followed	the	framework	proposed	by
Arksey	and	O’Malley	(31)	and	detailed	by	Levac,	Colquhoun	and	O’Brien	(32).	Arksey	and	O’Malley’s
framework	(31)	consisted	of	six	steps:	(i)	Identifying	the	research	question;	(ii)	identifying	relevant
studies;	(iii)	study	selection;	(iv)	charting	the	data;	(v)	collating,	summarizing	and	reporting	the
results;	(vi)	consultation.
The	review	protocol	was	designed	with	experts	in	the	field	of	rehabilitation	in	RNCs,	who	were
consulted	to	identify	inclusion/exclusion	criteria,	data	extraction	and	charting	process	(protocol
registered	on	Open	Science	Framework:	https://osf.io/4cr32/).
	
Step	1:	Identifying	the	research	question
The	research	question	of	this	scoping	review	was	developed	through	discussions	with	stakeholders
including	patients	and	support	groups	representatives	of	seven	rare	conditions	(Muscular	Dystrophy
Association,	Ataxia	UK,	Hereditary	Spastic	Paraplegia	support	group,	Progressive	Supranuclear	Palsy
Association,	Huntington’s	disease	Association,	Multiple	System	Atrophy	Trust,	Motor	Neurone	Disease
Association).
6	This	scoping	review	asked	the	following	research	questions:	i)	What	are	the	common	exercise	and
physical	activity	interventions	for	people	living	with	RNCs?	2)	What	are	the	characteristics	of	these
interventions	in	terms	of	frequency,	intensity,	time	and	type?	3)	What	outcome	measures	were	used
to	measure	intervention	efficacy?
	
Step	2:	Search	strategy
A	three-phase	search	strategy	was	designed,	as	outlined	in	the	Guidance	for	Conducting	Systematic
Scoping	Reviews	(33)	and	informed	by	advice	from	a	university	librarian.	A	preliminary	search	was
conducted	using	keywords,	such	as	physical	therapy,	physical	activity,	physiotherapy	or	exercise.
Relevant	keywords	in	the	title	and	abstracts	of	systematic	reviews	were	extracted	to	form	a	second
list	of	terms	that	was	used	to	undertake	the	final	searches	through	the	following	databases:	Pubmed,
Embase	and	CINAHL	(full	search	lists	can	be	found	in	Additional	file	1).
Finally,	the	reference	list	of	all	identified	systematic	reviews	was	hand-searched	for	additional	studies.
Authors	of	reviews	were	contacted	for	further	information,	as	required.
	
Step	3:	Selecting	studies
Inclusion	and	exclusion	criteria
1.	 Full-text	systematic	reviews	(including	meta-analyses)	in	English	from	2008	to	2018,
that	reported	on	physical	activity	and	exercise	intervention	studies	(including
randomised	controlled	trials,	quasi-experimental	studies,	controlled	and	pre-post
designs)	were	included.
2.	 Systematic	reviews	reporting	at	least	one	outcome	measure	on	physical	activity
and/or	exercise.	We	utilised	an	evaluation	framework	following	the	International
Classification	of	Functioning,	Disability	and	Health	(ICF)	(34)	and	we	divided	the
outcome	measures	according	to	their	level	of	body	structure/function	impairments
(e.g.	manual	muscle	strength	testing)	or	limitations	in	functional	activities	and
7participation	restrictions	(e.g.	daily	steps	count	or	measures	of	functional
independence).
3.	 Systematic	reviews	that	included	observational	studies	were	considered	for	inclusion
if	they	selectively	reported	on	interventional	evidence,	whilst	those	solely	reporting
on	findings	from	observational	studies	were	excluded.	Pharmacological	interventions
were	excluded.
4.	 Scoping	reviews	and	literature	reviews	were	excluded.
	
Population
Adults	(individuals	older	than	18	years)	at	study	entry,	with	one	of	the	following	neurological
conditions	(either	at	early	or	advanced	stages):	ataxias	(e.g.	Friedreich’s	ataxia),	HSP,	HD,	NMD	(e.g.
polyneuropathies,	myasthenia	and	muscular	dystrophies),	MND,	atypical	Parkinsonisms	(e.g.	MSA,
PSP).
	
Concept
Systematic	reviews	of	interventions	that	aimed	to	increase	the	quantity	(e.g.	steps	count)	or	change
the	quality	(e.g.	confidence	in	doing	activities)	of	physical	activity	at	either	the	body
structure/function	or	activity	and/or	participation	levels	(ICF	framework)	were	included.	Exercise
interventions	that	sought	a	change	in	physical	fitness	(e.g.	using	physiologic	parameters)	were	also
included.
Systematic	reviews	of	interventions	with	a	control	arm	that	fell	within	the	category	of	regular	physical
activity	(e.g.	treatment	as	usual	in	a	clinical	setting,	or	every-day	life	activity)	and/or	active
interventions	that	differed	quantitatively	(in	terms	of	intensity,	frequency	or	duration	of	physical
activity)	or	qualitatively	(e.g.	less	cognitively	challenging)	from	the	intervention	of	interest,	were
included.
Outcomes	related	to	physical	activity	(primary	outcomes)	and	indirect	outcomes	(secondary
8outcomes),	such	as	fatigue	and	psychological	symptoms	(e.g.	depression),	were	extracted	from	the
relevant	studies.	Outcome	measures	were	grouped	according	to	the	ICF	framework,	under	three	main
domains:	participation	restrictions,	limitations	in	functional	activities,	and	body	structure	and	body
function	impairments.
	
Context
Any	type	of	setting	(e.g.	home,	primary	health	care	or	the	community)	and	country	were	included	in
the	current	review.
	
Screening
Titles	and	abstracts	were	screened	manually	for	eligibility	by	one	reviewer	(VB)	against
inclusion/exclusion	criteria	and	those	that	were	clearly	outside	the	scope	of	the	review	were	excluded.
A	second	reviewer	(GR)	independently	screened	a	random	sample	of	10%	of	the	total	papers	(by	titles
and	abstracts)	for	inclusion	or	exclusion.	The	full-text	of	eligible	papers	was	extracted	and	checked	by
the	first	reviewer,	with	any	concerns	about	inclusion	discussed	with	two	members	of	the	team	and
resolved	by	consensus.	The	screening	process	was	detailed,	reporting	the	number	of	studies	selected
against	inclusion	criteria,	using	the	Preferred	Reporting	Items	for	Systematic	Reviews	and	Meta-
Analyses	(PRISMA)	flow	diagram	(35).
	
Step	4:	Charting	the	data	(data	extraction)
Data	extraction	from	each	eligible	review	was	conducted	by	one	reviewer	(VB).	The	data	extraction
process	included:	(i)	an	overview	of	the	main	characteristics	of	included	reviews	such	as	authors,	year
of	publication,	type	of	condition,	type	of	review	(systematic	review	with	or	without	meta-analysis),
aim,	inclusion	and	exclusion	criteria,	number	of	studies	retrieved	and	included/excluded,	quality	and
bias	assessment	method;	ii)	characteristics	of	studies	included	for	each	review,	such	as	study
designs,	number	and	participant	characteristics,	controls,	outcome	measures,	disease-specific
interventions	(using	the	FITT	model	-	frequency,	intensity,	time	and	type),	settings	and	study	quality;
9(iii)	a	summary	of	key	findings,	limitations	and	recommendations	for	each	review.
Step	5:	Collating,	summarising	and	reporting	data
A	descriptive	synthesis	of	common	interventions	was	produced,	accompanied	by	charting	tables.	A
summary	of	the	outcome	measures	utilised	was	presented	using	charts	and	tables	to	provide	an
overview	of	common	assessment	tools	across	different	conditions,	as	outlined	in	the	JBI	Reviewers’
Manual	(30).
	
Step	6:	Consultation
Experts	in	the	field	of	rehabilitation	in	RNCs	were	consulted	to	discuss	the	review	findings.
	
Results
Search	and	selection	of	included	reviews
Database	searches	identified	5435	articles,	and,	after	removing	duplicates,	4433	were	screened	by
titles	and	abstracts,	leaving	62	articles	for	full-text	eligibility	assessment.	After	full-text	screening,	27
articles	were	included	for	the	narrative	synthesis.	No	additional	sources	were	identified	from	the
reference	lists	of	included	studies.	Reasons	for	exclusion	were:	conference	abstract	(N	=	11),	no	full-
text	available	(N	=	2),	conditions,	research	design	and	outcome	measures	described	did	not	meet	the
inclusion	criteria	(N	=	13),	previous	version	of	included	systematic	review	(N	=	6)	and	systematic
reviews	included	the	same	studies	present	in	more	recent	reviews	(N	=	3)	(Fig.1).	The	second
reviewer	(GR)	screened	443	studies	randomly	selected	from	the	total	records	(without	duplicates)	and
did	not	identify	any	further	eligible	articles.
	
Figure	1.	PRISMA	flow	diagram
	
Included	systematic	reviews
An	overview	of	the	main	characteristics	of	included	reviews	is	outlined	in	Table	1.	More	detailed
information	is	presented:	i)	for	each	review	in	Additional	file	2	(i.e.	authors,	year	of	publication,	type
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of	condition);	ii)	for	studies	included	in	each	review	in	Additional	file	3	(e.g.	study	designs,	number
and	participant	characteristics);	(iii)	in	a	format	of	summary	of	key	findings,	limitations	and
recommendations	for	each	review	in	Additional	file	4.
	
Table	1.			Review	characteristics	of	included	studies
	
Out	of	27	articles,	16	involved	a	narrative	synthesis	(N	=	16)	and	were	published	from	2013	onwards.
Most	systematic	reviews	aimed	to	examine	the	evidence	for	an	effect	of	any	type	of	intervention	(N	=
9),	exercise	training	(N	=	6)	or	a	rehabilitation	intervention	(N	=	4)	in	rare	neurological	conditions.
Most	studies	investigated	people	with	NMDs	(N	=	13),	including	a	number	of	muscle	diseases	(e.g.	
myotonic	dystrophy)	(N	=	1),	myotonic	dystrophy	and	Welander	distal	myopathy	(N	=1),	muscular
dystrophy	(N	=1),	Welander	distal	myopathy,	muscular	dystrophies	and	Hereditary	inclusion	body
myopathies	(N	=1),	idiopathic	inflammatory	myopathies	(N	=	1),	Charcot-Marie-Tooth	disease	(N	=3),
McArdle	disease	(N	=1),	Guillain-Barre´	Syndrome	(N	=	2),	critical	illness	myopathy	and
polyneuropathy	(N	=1)	and	Postpolio	syndrome	(N	=1).	More	than	half	of	reviews	included	one	to	five
intervention	studies	for	each	review	(N	=	18).	Twenty	systematic	reviews	included	at	least	one	RCT	in
their	reports,	whilst	the	remaining	studies	included	at	least	a	quasi-randomized	controlled	design	(N	=
1),	observational	prospective	design	(N	=	1),	case-control	design	(N	=	3)	or	pre-post	design	(N	=	2).
Some	intervention	studies	were	reported	in	multiple	reviews.	In	particular,	Lui	and	Byl	(36)	and
Arbesman	and	Sheard	(37)	included	one	randomized	trial	(38)	and	a	quasi-randomized	trial	(39)	that
were	discussed	in	Dal	Bello-Haas	et	al.	(40).	Therefore,	the	two	studies	were	described	only	once	in
Dal	Bello-Haas	et	al’s	review	(40).	In	Marquer,	Barbieri	and	Pe´rennou	(41),	four	intervention	studies
were	relevant	for	the	aim	of	the	present	scoping	review,	however,	only	one	was	reported	in	the	result
section,	as	the	remaining	three	studies	were	already	presented	in	Fonteyn	et	al.	(42).
The	systematic	review	with	the	smallest	number	of	participants	included	18	individuals	in	total	(43),
whilst	the	one	with	the	largest	sample	included	779	(44),	followed	by	757	(45)	and	435	(16),	which
investigated,	respectively,	the	effect	of	multidisciplinary	care		in	individuals	living	with	MND	(44),	and
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any	type	of	interventions	in	individuals	with	NMDs	(45),	and	physical	therapy	in	people	with	HD	(16)
(see	Additional	file	2).
In	line	with	the	stated	aims	of	the	review,	findings	have	been	grouped	by	types	of	interventions	and
conditions	(Fig.	2).	Systematic	reviews	identified	the	following	types	of	training:	muscle	strength
training	(N	=	2)	and	aerobic	training	(N	=	1)	in	individuals	with	NMDs;	respiratory	training	in
individuals	with	MND	(N	=	2);	combined	interventions	in	individuals	with	NMDs	(N	=	10),	Ataxias	(N	=
4),	MND	(N	=	4),	HD	(N	=	2)	and	PSP	(N	=	2).	FITT	characteristics	varied	considerably,	both	within	and
between	reviews,	however,	they	are	reported	in	Table	2	where	possible,	for	each	intervention.
	
Figure	2.	Summary	of	types	of	interventions	per	condition
Figure’s	legend:	NMDs	=	neuromuscular	diseases;	MND	=	motor	neurone	disease;	HD	=
Huntington’s	disease;	PSP	=	progressive	supranuclear	palsy
Combined	interventions
Twenty-two	reviews	across	all	RNCs	identified	in	this	scoping	review	included	combined	interventions.
Frequency,	intensity	and	time	varied	considerably	between	studies,	with	interventions	lasting
between	one	to	260	weeks,	ranging	between	one	to	seven	sessions	per	week,	with	each	session
lasting	10	minutes	to	eight	hours	(Table	2).	Similar	interventions	across	conditions	were:	muscle
strength	exercises,	stretching,	aerobic	training,	multidisciplinary	interventions	and	gait	training.	Gait
training	and	balance	exercises	were	reported	in	all	conditions	with	the	exception	of	MND.	Details	on
intervention	intensity	and	frequency	were	not	routinely	reported,	especially	in	the	MND	and	ataxia
reviews.
	
Table	2.	Number	of	reviews	per	condition	and	FITT	characteristics	for	combined
interventions
Ten	reviews	(25,	27,	43,	45-51)	addressed	the	effect	of	combined	interventions	in	individuals	with
NMDs	(Charcot-Marie-Tooth	disease,	Guillain-Barre´	Syndrome,	myotonic	dystrophy	and	Welander
distal	myopathy,	idiopathic	inflammatory	myopathy,	post-polio	syndrome,	Welander	distal	myopathy,
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Becker	muscular	dystrophy,	limb-girdle	muscular	dystrophies,	hereditary	inclusion	body	myopathies,
polymyositis	and	dermatomyositis,	facioscapulohumeral	muscular	dystrophy,	mitochondrial
myopathy,	critical	illness	myopathy	and	polyneuropathy).		
Combined	interventions	in	NMDs	included:	hand	exercises	(i.e.	isolated	and	mass	movements	with
silicone-based	putty	combined	with	resistance	and	stretching	exercises);	aerobic	training	(e.g.
walking,	bicycle	training,	step	aerobics,	home	training	of	stationary	bicycle	ergometer);	body	weight
support	exercises,	muscle	strength	training,	strength	exercises	combined	with	breathing	exercises,
stretching,	education,	self-care	education	combined	with	home	training,	psychological	and	social
support,	passive	or	active	motion	sessions,	functional	exercises,	multidisciplinary	goal-oriented
rehabilitation	based	on	functional	treatment,	physical	therapy	training	based	on	neurodevelopment
sequences,	positioning,	wobble	board,	gait	training	and	occupational	therapy.
Four	reviews	(36,	37,	40,	44)	addressed	the	effect	of	combined	interventions	in	individuals	living	with
MND,	including:	supervised	proprioceptive	neuromuscular	facilitation	(PNF)	patterns	combined	with
strength	and	a	home	exercise	programme	(stretching	combined	with	a	range	of	motion	exercises),
slow	reversals	resistance	techniques,	treadmill	with	biphasic	positive	airway	pressure,	individualized
and	progressive	exercise,	moderate	intensity,	moderate	load	resistance	exercises	and	daily	stretching
exercises,	endurance	type	exercises	for	limbs	and	trunk.	One	review	investigated	the	effect	of
multidisciplinary	care,	including	a	consultant	in	rehabilitation,	occupational	therapist,	physical
therapist,	speech–language	pathologist,	dietician,	and	social	worker	(44).
Two	reviews	(16,	52)	addressed	the	effect	of	combined	interventions	in	individuals	living	with	HD,
including:	exercise	individualised	addressing	maintenance	of	functional	ability,	flexibility,	strength,
video	based	exercise	designed	to	reduce	impairment	and	promote	balance,	physiotherapist	instructed
stretches,	coordination,	balance,	one	leg	balance	and	tandem	walking	and	upper	limb	ball	exercises,
respiratory	intervention,	facial	exercise,	whole	body	exercises	in	lying	standing	and	sitting	for	gait,
transfer	training,	postural	training,	a	multi-sensory	stimulation	intervention,	gait	therapy,	cycling,
resistance	exercises	and	aerobic	exercise,	use	of	videogames,	PNF	intervention,	functional	activities,
combination	with	occupational	therapy	and	social	activities.
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Four	systematic	reviews	(41,	42,	53,	54)	addressed	the	effect	of	combined	interventions	in	individuals
living	with	ataxias,	including:	coordination,	balance,	and	muscular	conditioning	exercise,	physical
therapy,	with	a	focus	on	balance,	gait,	general	conditioning,	muscle	strength	and	range	of	motion,
coordinative	training	with	the	main	goal	of	being	able	to	activate	and	engage/control	mechanisms	of
balance,	multi-joint	coordination,	occupational	therapy	(daily	activities	such	as	accessing	to	food,
clothing,	personal	hygiene,	and	leisure	were	some	of	the	main	disabilities	focused	by	these	patients).
Two	systematic	reviews	(55,	56)	addressed	the	effect	of	combined	interventions	in	individuals	living
with	PSP,	including:	balance	training	complemented	with	eye	movement	and	visual	awareness
training	(versus	balance	training	alone	and	limb	coordination	activities),	fine	motor	activities,	tilt
board	balancing,	ambulation	training,	exercises	to	improve	strength	and	coordination,	static	and
dynamic	balance,	resistive	and	isokinetic	exercises,	Biomechanical	Ankle	Platform	System,	physical
exercises,	modified	body	weight	support	treadmill,	wearable	audio-biofeedback	device/Dynamic
Antigravity	Postural	System;	Vibration	Sound	system,	exercise	programme	of	stretching,	treadmill
with	and	without	body	weight	support,	physical	therapy	exercises	and	Xbox	Kinect,	Virtual	Gaming
System,	robot-assisted	gait	training,	using	end-effector	robotic	rehabilitation	locomotion	training	(G-
EO	system	device),	multidisciplinary	intensive	rehabilitation	treatment.
	
Muscle	strength	training
Two	systematic	reviews	(28,	57)	included	interventions	lasting	from	12	to	52	weeks	and	investigating
strength	training	in	individuals	living	with	NMDs,	including:	general	muscle	involvement	or	selected
muscles,	dynamic	and	isometric	strength	training	with	weights.	Frequency	of	interventions	was	not
reported	in	both	studies,	while	intensity	ranged	between	30	and	60	minutes	per	session.
	
Aerobic	training
One	systematic	review	included	three	non-randomised	studies	lasting	8	to	32	weeks	and	investigating
aerobic	training	such	as	walking	and	cycling	in	individuals	living	with	NMDs.	Each	session	lasted
between	45	and	60	minutes	with	a	frequency	of	three	to	five	times	per	week	(58).
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Respiratory	training
Two	systematic	reviews	included	studies	lasting	from	12	weeks	to	32	months	and	investigating
respiratory	training	in	individuals	living	with	MND,	including:	respiratory	training	muscle	and	yoga
breathing	technique.	In	one	study,	duration	per	session	was	10	minutes,	while	other	studies	reported
10	to	15	repetitions	per	sessions,	two	to	five	times	a	day,	every	day	(29,	59).
	
Outcome	measures
A	total	of	189	outcome	measures	were	identified	across	the	included	reviews.	Of	these,	the	majority
were	related	to	body	function	impairments	(47%)	and	limitation	in	functional	activities	(27%),
followed	by	participation	restrictions	(6%)	and	body	structure	impairments	(5%).	Two	domains	did	not
fall	into	the	ICF	classification	and	were	categorised	as	“Other”	(e.g.	Goal	attainment	score)	(8%),	and
“Disease-specific”	questionnaires	(e.g.	Unified	Huntington's	Disease	Rating	Scale	or	Scale	for	the
Assessment	and	Rating	of	Ataxia)	(7%).	The	full	list	of	the	outcome	measures	can	be	found	in
Additional	file	5.
Most	reviews	included	studies	using	outcome	measures	related	to	the	domain	of	body	function
impairments	(N	=	26),	followed	by	limitation	in	functional	activities	(N	=	17),	participation	restrictions
(N	=	13)	and	body	structure	impairments	(N	=	5)	(Table	3).	Notably,	none	of	the	outcome	measures
included	were	agreed	with	the	involvement	of	service	users	or	members	of	the	public.
Eleven	reviews	included	studies	using	disease-specific	outcome	measures,	while	in	six	reviews,
studies	used	other	measures	that	did	not	fall	into	the	ICF	domains	(i.e.	in	the	“Other”	category),	such
as	goal	attainment	or	hospital	readmissions	and	length	of	stay.	Most	reviews	used	a	combination	of
three	to	five	different	domains	(N	=	17),	while	in	eight	reviews	two	domains	were	present.	One
domain	was	identified	in	two	reviews	(Table	3)
	
Table	3.	ICF	domains	identified	for	each	study
Discussion
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The	aim	of	this	scoping	review	was	to	synthesise	the	body	of	evidence	in	relation	to	physical	activity
and	exercise	interventions	utilised	across	a	wide	range	of	RNCs.	As	part	of	this,	the	review	sought	to
explore	the	range	and	focus	of	outcome	measures	used	in	these	studies.
	
Rare	diseases	under	study
The	majority	of	the	studies	were	conducted	in	people	with	NMDs,	followed	by	MND,	hereditary
ataxias,	HD,	and	PSP.	The	prevalence	of	studies	identified	in	NMDs	was	expected,	due	to	the	fact	that
they	do	not	represent	only	one	disease	entity,	but	approximately	60	diseases	under	one	umbrella	that
affect	the	peripheral	nerves,	neuromuscular	junction	or	muscles	tissue	(60).	Some	of	the	systematic
reviews	identified	explored	specific	groupings	within	NMDs,	for	example	only	muscle	disease	(27)	or
inherited	peripheral	neuropathy	(48,	57).	Thus,	the	reviews	do	not	represent	interventions	across	a
range	of	NMDs,	and	may	falsely	inflate	the	apparent	number	of	reviews,	when	in	reality	they	focus	on
individual	neuromuscular	conditions.
HSP	was	one	of	the	included	conditions,	however,	no	systematic	reviews	were	identified	at	the	time	of
searches.	The	overall	literature	in	this	condition	is	limited	to	case	studies	of	rehabilitation
interventions	(61)	and	small	studies	of	hydrotherapy	(62)	or	robot	gait	training	(63,	64),	as	confirmed
in	a	recent	systematic	review,	identified	subsequently	to	our	scoping	review	searches	(23).	The
authors	of	this	recent	systematic	review	rated	the	overall	quality	of	physical	interventions	in	HSP	as
low.	HSP	has	a	similar	prevalence	to	HD	and	PSP,	so	it	is	unclear	why	there	is	a	paucity	of	literature	in
physical	activity	or	exercise	interventions	in	this	group	(65).
	
Physical	Activity	Interventions
Most	reviews	included	studies	of	structured	exercise	using	body	function	and	functional	activity
primary	outcomes.	These	studies	investigated	muscle	strength	training,	aerobic	training,	respiratory
training	and	combined	interventions	encompassing	muscle	strength	exercises,	stretching,	aerobic
training,	multidisciplinary	interventions	and	gait	training.	The	interventions	were	prescribed	and
progressed	by	health	care	or	exercise	professionals	and	followed	the	FITT	principles.	Many	were
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standardised	programmes,	but	variability	existed	in	the	prescription	with	only	approximately	one	third
adhering	to	the	American	College	of	Sports	Medicine	recommendations	(66).	Variation	was	also	seen
in	the	type	of	training	with	resistance	training	(skeletal	or	inspiratory	muscles),	aerobic	training	or	a
mixture	of	the	two.	In	addition,	functional	training,	using	gait	trainers,	was	included	in	some	reviews.
Some	were	used	to	increase	aerobic	capacity	and	others	aimed	to	improve	walking	parameters	such
as	daily	step	counts,	speed,	or	stance/swing	time.
The	level	of	evidence	mostly	ranged	from	low	to	uncertain	and	a	common	finding	across	the	reviews
was	the	methodological	limitations,	characterised	by	small	sample	sizes,	variation	in	exercise	dose
and	training	duration.	Despite	these	limitations,	some	reviews	reported	on	adverse	events	and
recommended	exercise	to	be	safe	(27,	36,	45,	46,	50,	58).	Other	reviews	recommended	caution	when
interpreting	findings	(16,	48,	49,	53),	due	to	heterogeneity	in	intervention	characteristics,	outcome
measures,	insufficient	high-quality	studies	and	likelihood	of	Type	II	errors.
In	most	reviews,	authors	warranted	further	research	for	more	definitive	answers	on	intervention
effectiveness.	However,	in	Charcot-Marie-Tooth	disease	and	cerebellar	ataxias,	there	was	low	to
moderate	evidence	of	efficacy	of	structured	exercise	(41,	42,	47,	48)	whilst,	in	MND,	structured
exercise	was	recommended	for	inclusion	in	rehabilitation	and	management	of	these	diseases	(29,	36).
Very	few	reviews	focused	on	behaviour	change	interventions	to	increase	participation	in	physical
activity	and/or	structured	exercise.	Behaviour	change	interventions	are	psychology-based	and
promote	changes	in	individual	capability	and	motivation	to	engage	in	a	certain	activity,	and	provide
opportunity	to	make	the	behaviour	change	possible	(67).	They	have	been	investigated	in	other
neurological	conditions,	such	as	multiple	sclerosis	and	stroke,	and	long-term	conditions	such	as
diabetes	and	prostate	cancer	(68-72).	In	our	scoping	review,	there	was	no	evidence	of	behaviour
change	interventions	based	on	participant	choice,	and	strategies	to	increase	individual	self-efficacy
and	help	patients	make	decisions	on	activities	they	would	feel	motivated	to	try.	Education	and	multi-
disciplinary	goal	setting	were	used	in	trials	of	rehabilitation	on	Guillain-Barre’	syndrome,	but	this
pertained	to	shorter	term	rehabilitation	programmes	(i.e.	12	weeks)	(51),	as	opposed	to	longer	term
behaviour	change.	
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Since	this	scoping	review	was	undertaken,	additional	systematic	reviews	have	been	published.	There
has	been	an	update	to	the	Cochrane	review	on	exercise	in	muscle	diseases	(22)	in	particular	in	spinal
muscular	atrophy.	The	review	identified	one	randomised-controlled	trial	(73)	investigating	the	effects
of	a	home-based,	muscle	strength	intervention	combined	with	cycle	ergometer	training	programme	in
14	people	with	spinal	muscular	atrophy	for	six	months	(22).	In	the	above	study,	no	detectable
changes	were	identified	on	measure	of	function,	cardiopulmonary	exercise	capacity,	quality	of	life	and
fatigue	and	the	authors	graded	the	study	quality	as	very	low,	and	warranted	future	well-designed	and
adequately	powered	studies.
Two	systematic	reviews	have	been	conducted	recently	on	the	effect	of	exercise	in	HD.	The	first	review
meta-analysed	the	evidence	for	efficacy	and	safety	of	physical	exercise	interventions	across	six
chronic	brain	disorders	including	HD		(74).	The	overall	effect	size	across	studies	was	positive	on
depressive	symptoms,	quality	of	life,	cognition	(e.g.	attention	and	working	memory,	executive
functioning),	however,	separate	analyses	did	not	show	positive	effects	on	these	outcomes	in
individuals	with	HD.	A	second	systematic	review	investigated	the	effect	of	exercise	on	high-level
mobility	(e.g.	running	or	jumping)	in	individuals	with	neurodegenerative	disease,	such	as	multiple
sclerosis,	Parkinson’s	disease,	HD	and	degenerative	cerebellar	disease	(24).	However,	no	new	studies
involving	participants	living	with	rare	conditions	were	identified	in	the	review,	as	the	two	intervention
studies	included	(17,	75)	were	reviewed	in	two	previous	systematic	reviews	included	in	the	present
scoping	review	(16,	53).
	
Outcome	measures
Similar	to	the	interventions	described	in	the	present	review,	outcome	measures	were	highly	variable
across	the	included	systematic	reviews	and	mostly	assessed	changes	at	the	levels	of	body	function
(e.g.	manual	muscle	strength	testing)	and	functional	activities	(e.g.	6	minute	walking	test),	perhaps
reflecting	the	intent	of	researches	to	measure	efficacy	of	structured	exercise	interventions.	The	few
outcomes	identified	at	the	level	of	participation	primarily	measured	quality	of	life,	including	life
satisfaction	and	well-being,	and	were	documented	in	less	than	half	of	reviews.	The	major	focus	on
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function	and	activity	measures,	as	opposed	to	participation	in	activities,	highlights	a	lack	of	attention,
and	perhaps	understanding,	on	the	non-motor	effects	of	physical	activity	and	exercise,	an	area	that	is
critically	important	for	people	with	RNCs.	Exploring	the	areas	for	change,	important	for	people	living
with	RNCs,	represents	an	important	step	that	requires	attention	in	prospective	evaluations	to	ensure
that	the	research	is	relevant	to	study	participants,	and	ultimately,	in	clinical	practice	(76).	Further
exploration	is	needed	to	achieve	consensus	between	researchers	and	members	of	the	public	on
recommended	participatory	focussed	outcome	measures.	Furthermore,	given	the	common	challenges
experienced	by	people	living	with	RNCs,	alongside	the	importance	to	maintain	a	united	approach
across	conditions,	there	is	an	urgent	need	to	define	a	core	and	standardised	outcome	measure	set
across	the	wide	spectrum	of	RNCs.	This	outcome	measure	set	would	greatly	benefit	the	synthesis	of
future	studies	on	physical	activity	and	exercise	interventions.
	
Conclusion
Although	our	aim	was	to	include	physical	activity	interventions	of	any	kind,	the	vast	majority	of
systematic	reviews	identified	in	this	scoping	review	encompassed	structured	exercise	that	aimed	to
change	physical	activity	measured	at	the	level	of	body	function	and	functional	activity.	Structured
exercise	can	be	considered	one	way	to	improve	physical	functioning,	but	people	with	rare	diseases
may	find	it	hard	to	access	or	sustain	this	type	of	activity.	Physical	activity	includes	any	body
movement	and	has	the	scope	to	bring	similar	improvements	with	activities	that	are	accessible	and
engaging	to	people	living	with	significant	disability.	A	focus	on	supporting	people	to	become	more
active	may	facilitate	lifelong	engagement	rather	than	the	short	term	training	programmes	that	have
been	investigated	to	date.		As	common	physical,	cognitive	and	psychological	challenges	are	often
faced	by	people	with	RNCs,	these	may	be	helped	by	increasing	engagement	in	physical	activity,
irrespective	of	type	of	exercise	or	activity	and	rare	condition.	Being	more	physically	active	has	wide
health-related	and	emotional	benefits,	beyond	improvements	at	the	body	structure	and	functional
activity	levels.	Future	interventions	should	consider	activities	meaningful	to	individuals,	and	how
these	could	be	integrated	into	people’s	daily	life.
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Tables
	
Table	1.			Review	characteristics	of	included	studies
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Review
characteristics
	 Count
Review	type Narrative	synthesis 16
Cochrane	reviews 6
Meta-analysis 2
Systematic	review	as	part	of	practice	recommendations 2
Mixed-methods 1
Year	publication 2008
2009-2010																																																																																																
2
3
2011-2012 5
2013-2014 8
2015-2016 6
2017-2018 3
Disease	studied Neuromuscular	diseases 13
Motor	neurone	disease 6
Ataxias 4
Huntington’s	disease 2
Progressive	supranuclear	palsy 2
Review	aim Evidence	for	treatment	(any	type) 9
Safety	and/or	efficacy	for	exercise	training 6
Efficacy	for	rehabilitation 4
Safety	and/or	efficacy	for	strength	and/or	aerobic	training 3
Efficacy	for	respiratory	muscle	training 2
Evidence	for	occupational	therapy 2
Efficacy	for	multidisciplinary	interventions 1
Number	of	studies
for	each
systematic
review		
1-5 18
6-10 3
11-15 4
16-20 2
	
	
Table	2.	Number	of	reviews	per	condition	and	FITT	characteristics	for	combined	interventions
30
Reviews	per	condition Frequency Intensity	(per	session) Time
Neuromuscular	diseases	N	=	10 2	to	5	times	a	week 10	to	180	minutes 1		to	52	weeks
Moto	neurone	disease	N	=	4 2	 to	 5	 times	 a	 week	 (when
reported)
15	minutes	(mostly	not	reported) 6	to	48	weeks
Ataxias	N	=	4 1	 to	 7	 times	 a	 week	 (when
reported)
15	 to	 120	 minutes	 (mostly	 not
reported)
4	to	260		weeks
Huntington’s	disease	N	=	2 1	to	6	times	a	week 30	minutes	to	8	hours	(intensive) 1	day	to	52	weeks
Progressive	supranuclear	palsy	N	=
2
2	to7	times	a	week 45	to	60	minutes 4	to	130	weeks
					
	
Table	3.	ICF	domains	identified	for	each	study
Authors Condition
included
Body-
structure
Body-
function
Activit
y
Participatio
n
Disease-specific
Voet	et	al.
(2013)
Muscle	diseases
(myotonic
dystrophy,
polymyositis	and
dermatomyositis,
facioscapulohumer
al	muscular
dystrophy,
mitochondrial
myopathy)
	 ✓ 	 ✓ 	
Cup	et	al.	(2008) Myotonic	dystrophy
and	Welander
distal	myopathy
	 ✓ ✓ ✓ 	
Gianola	et	al.
(2013)
Muscular	dystrophy 	 ✓ ✓ 	 	
Narayanaswami
et	al.	(2014)
Welander	distal
myopathy,	Becker
muscular
dystrophy,	Limb-
girdle	muscular
dystrophies,
Hereditary
inclusion	body
myopathies
✓ ✓ 	 	 	
Habers	and
Takken	(2011)
Idiopathic
inflammatory
myopathy
(dermatomyositis,
polymyositis,	and
inclusion	body
myositis)
✓ ✓ 	 ✓ 	
Ydemann,
Eddelien	and
Lauritsen	(2012)
Critical	illness
myopathy	and
polyneuropathy
	 ✓ ✓ ✓ 	
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Young	et	al.
(2008)
Charcot-Marie-
Tooth	disease
	 ✓ ✓ 	 	
Sman	et	al.
(2015)
Charcot-Marie-
Tooth	disease
✓ ✓ ✓ 	 ✓
Corrado,	Ciardi
and	Bargigli
(2016)
Charcot-Marie-
Tooth	disease
✓ ✓ ✓ 	 	
Quinlivan	et	al.
(2011)
McArdle	disease ✓ ✓ 	 	 	
Koopman	et	al.
(2015)
Postpolio	syndrome 	 ✓ ✓ 	 	
Arsenault	et	al.
(2016)
Guillain-Barre´
Syndrome
	 ✓ ✓ ✓ ✓
Khan	and
Amatya	(2012)
Guillain-Barre´
Syndrome
	 ✓ ✓ ✓ 	
Dal	Bello-Haas	et
al.	(2013)
Motor-neuron
disease
	 ✓ 	 ✓ ✓
Lui	and	Nancy
(2009)
Motor-neuron
disease
	 ✓ 	 	 ✓
Eidenberger	and
Nowotny	(2014)
Motor-neuron
disease
	 ✓ ✓ ✓ ✓
Ferreira	et	al.
(2016)
Motor-neuron
disease
	 ✓ ✓ 	 	
Abersman	and
Sheard	(2014)
Motor-neuron
disease
	 ✓ 	 ✓ ✓
Ng	and	Khan
(2009)
Motor-neuron
disease
	 	 	 ✓ ✓
Quinn	and	Busse
(2012)
Huntington’s
disease
	 ✓ ✓ ✓ ✓
Fritz	et	al.	(2017) Huntington’s
disease
	 ✓ ✓ 	 	
Trujillo-Martı´n	et
al.	(2009)
Spinocerebellar
ataxia
	 ✓ 	 	 	
Fonteyn	et	al.
(2014)
Cerebellar	Ataxia 	 ✓ ✓ ✓ ✓
Milne	et	al.
(2017)
Genetic
degenerative
ataxia
	 ✓ ✓ ✓ ✓
Marquer,	Barbieri
and	Pe´rennou
(2014)
Cerebellar	Ataxia 	 ✓ 	 	 	
Hajjar	and
Cooper	(2016)
Progressive
supranuclear	palsy
	 ✓ ✓ 	 	
Intiso	et	al.
(2018)
Progressive
supranuclear	palsy
	 ✓ ✓ 	 ✓
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Figure	1
PRISMA	flow	diagram
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Figure	2
Summary	of	types	of	interventions	per	condition
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